Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of fangchinoline for preparing medicine for treating or preventing HIV

A technology for fangchinoline and HIV, applied in the field of medicine, can solve the problems of virus variability and drug resistance, large toxic and side effects, high price, etc., and achieve the effects of wide sources and novel targets.

Inactive Publication Date: 2013-04-24
WUHAN INST OF VIROLOGY CHINESE ACADEMY OF SCI
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this kind of therapy is expensive, has high toxicity and side effects, cannot completely eliminate HIV in the human body, and is easy to cause mutation and drug resistance of the virus
There is no report on anti-HIV-1 effect of fangchinoline

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of fangchinoline for preparing medicine for treating or preventing HIV
  • Application of fangchinoline for preparing medicine for treating or preventing HIV
  • Application of fangchinoline for preparing medicine for treating or preventing HIV

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Example 1: Cytotoxicity and anti-HIV activity of fangchinoline in MT-4 cells

[0028] In this example, Cell TiterGlo (promega product) reagent was used to quantitatively detect cell activity to determine the cytotoxicity of fangchinoline, and p24 ELISA (the p24ELISA kit was purchased from Wuhan Institute of Virology, Chinese Academy of Sciences) was used to detect the cytotoxicity of fangchinoline. The virus content in the supernatant of infected cells was used to determine the antiviral activity of the drug. The specific experimental method is as follows.

[0029] Cytotoxicity test: MT-4 cells (from the National Institute of Allergy and Infectious Diseases) were stored at 37°C, 5% CO 2 cultured in a humidified incubator. Cultured in 1640 culture medium containing 10% FBS, 100 U / mL penicillin and streptomycin, and timed subculture to ensure that the cell density was 1×10 5 ~1×10 6 / mL. In the drug toxicity detection experiment, 2-fold serially diluted fangchinoline...

Embodiment 2

[0034] Example 2: Effect of fangchinoline on the early stages of the HIV-1 replication cycle

[0035] In order to study the antiviral mechanism of fangchinoline, this embodiment uses the MT-4 cell protection experiment and the TZM-b1 reporter cell experiment to detect the antiviral activity of the drug simultaneously. Institute) to determine whether fangchinoline acts on the early stages of the HIV-1 replication cycle. In the MT-4 protection assay, HIV-1 undergoes multiple rounds of replication and causes cytopathic effects, and all anti-HIV-1 drugs can show activity in this assay. TZM-b1 cells (from the National Institute of Allergy and Infectious Diseases) stably express the HIV receptor CD4, the co-receptors CXCR4 and CCR5, and the reporter gene (firefly luciferin) controlled by the HIV-1 promoter LTR is integrated in the genome Enzyme), the expression of Tat after virus infection can promote the expression of reporter gene, so, in this system, only antiviral drugs that ac...

Embodiment 3

[0042] Example 3: Effect of Fangchinoline on the Production of Infectious Virus Particles

[0043] In this experimental system, the HIV genome is directly transfected into cells so that the HIV life cycle consists only of gene expression, viral particle packaging, secretion and maturation. This experiment can be used to verify whether the drug acts on late events in the HIV life cycle. Take 293T cells in the logarithmic growth phase (purchased from the American Type Culture Collection), and use 5×10 cells per well. 4 / wells were laid on a 24-well plate for later use. The next day, the plasmid pNL4.3 was transfected by liposome method (Lipofactamine 2000, Invitrogen Company), and the fresh culture medium containing the drug was replaced after 3 hours. After 48 hours of transfection, Cell TiterGlo was used to detect cell viability; p24ELISA was used to detect the production of virus particles; TZM-b1 reporter cells were used to detect progeny virus infectivity. The p24 antige...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of fangchinoline for preparing medicine for treating or preventing HIV. The fangchinoline can dosage-dependently inhibit the copying of HIV-1 under in-vitro condition, and can inhibit the copying of HIV-1 by the percentage of more than 97% under nontoxic concentration on cell. The fangchinoline acts on the later period in a virus copying period, and the action mechanism is different from all the antiviral drugs on the market, and the effect target is new. The fangchinoline is taken as an effective component of traditional Chinese medicinal materials such as Radix Stephaniae Tetrandrae, the source is wide, the fangchinoline has the advantages of safety and low toxicity, and has wide prospect for exploitation of anti-HIV-1 drugs.

Description

technical field [0001] The invention belongs to the technical field of medicine, and more specifically relates to the application of fangchinoline base in the preparation of drugs for treating or preventing HIV. Background technique [0002] AIDS, also known as acquired immunodeficiency syndrome (AIDS), is an infectious disease caused by human immunodeficiency virus (human immunodeficiency virus, HIV) and characterized by severe damage to the systemic immune system. In 2007, a total of 33 million people worldwide were living with HIV, 2.7 million newly infected people, and 2 million people died of AIDS-related diseases. The AIDS epidemic in my country is accelerating, and HIV is spreading to the general population. In 2009, 740,000 HIV-infected and AIDS patients survived. The epidemic of AIDS is a serious threat to human health and the development of the global economy. [0003] HIV is an RNA virus belonging to the family Retroviridae and the genus Lentivirus. During HIV ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4725A61P31/18
Inventor 陈绪林万志涛
Owner WUHAN INST OF VIROLOGY CHINESE ACADEMY OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com